The interaction between SM (Sec1/Munc18) and SNARE (soluble N-ethylmaleimide-sensitive factor-attachment receptor) proteins constitutes the core eukaryotic membrane fusion machinery which manages exocytosis by mediating fusion of constitutively exocytic vesicles with the plasma membrane. However, mechanistic details on the nature and the physiological impact of SM-SNARE interactions remain largely elusive. Detailed characterization of the interaction profiles between Munc18b and its cognate SNAREs, Stx3 (syntaxin 3), SNAP-23 (soluble N-ethylmaleimideattachment protein 23) and VAMP8 (vesicle-associated membrane protein 8), revealed that Munc18b binds Stx3, VAMP8 and the assembled core SNARE complex consisting of Stx3, SNAP-23 and VAMP8. Dissection of the Munc18b-Stx3 heterodimer suggested that Munc18b interacts with Stx3's conserved Npeptide as well as with its closed-conformation C-terminus encompassing the Habc domain, a linker and the SNARE (H3) motif. Deletion of the Habc domain or mutations interrupting the intramolecular binding of the Habc and H3 domains abrogated the Munc18b-Stx3 interaction. Although only the N-peptide deletion mutant, but not the soluble wild-type Stx3, is assembled into the core SNARE complex in the presence of Munc18b in vitro, ectopic expression of this SM protein increases constitutive exocytosis in mammalian cells. Our results suggest that Munc18b is functionally coupled to the assembly of exocytic SNARE complexes and increases exocytosis by interacting with the N-peptide and closed-conformation C-terminus of Stx3, thereby neutralizing the secretion-inhibitory effect of this SNARE.
INTRODUCTION
In all eukaryotic cells, membrane-bound transport vesicles shuttle proteins and lipids between subcellular compartments and manage exocytosis such as synaptic neurotransmitter release [1] . A critical step in vesicle-dependent membrane trafficking is vesicular fusion with target compartments, which is mediated by cognate SNARE [soluble NSF (N-ethylmaleimide-sensitive factor) attachment receptor] proteins anchored in the transport vesicles (v-SNAREs) and the target membranes (t-SNAREs) via hydrophobic TMDs (transmembrane domains) or posttranslational fatty acid modifications [2, 3] . Although the VAMP (vesicle-associated membrane protein) (v-SNARE) is relatively small, composed of only one α-helical bundle known as a SNARE motif, t-SNAREs, including Stx (syntaxin) and either SNAP (soluble NSF-attachment protein)-23 (non-neuronal cell) or SNAP-25 (neuronal cells only), are more complex. SNAP-23 and SNAP-25 have two SNARE motifs, but lack the typical TMD common to most other SNAREs [2] . Stx proteins contain a large N-terminal region consisting of three autonomously folded α-helical bundles (Habc domain), an unfolded linker and a SNARE motif (also referred to as H3 domain [2, 3] ). Although in vitro studies revealed that fusion can be triggered by the apposed v-/tSNAREs [4, 5] , which assemble into an evolutionarily conserved ternary core SNARE complex [6, 7] , it has become clear that other regulatory factors are required to ensure and fine-tune specificity and efficiency of vesicular fusion under physiological conditions. Soluble SM (Sec1/Munc18) proteins have been shown to be essential for all vesicle-membrane fusion events occurring during intracellular trafficking which they modulate via interaction with their cognate SNARE proteins [8, 9] . Biochemical and structural studies have revealed at least four distinct SM-SNARE interactions that are functionally relevant for the vesiclemembrane fusion process: (i) the N-terminus (N-peptide) of Stx [10] [11] [12] [13] [14] [15] [16] [17] , (ii) the closed-conformation C-terminus of Stx, in which the Habc domain is associated with the H3 motif of the same protein and prevents assembly of H3 into SNARE complexes [18] [19] [20] [21] , (iii) the assembled core (v-/t-) SNARE complexes [16, [22] [23] [24] [25] , and (iv) non-Stx SNAREs [16, 24, 26, 27] .
Since most SM proteins were shown to bind assembled core SNARE complexes, they were long thought to stimulate SNARE interactions and promote exocytosis [9] . However, deriving a common role for SM proteins in exocytosis from genetic and structural evidence [10, 17, 19, 28] is far from conclusive and remains controversial. In particular, since neuronal Munc18a and its yeast homologue Sec1 were found to increase the rate of SNAREmediated membrane fusion [16, 29] , whereas the closely related Munc18c was shown to have an opposite effect [27] . Therefore precise characterization of SM protein function and dynamics Abbreviations used: Cy5, indodicarbocyanine; DAPI, 4 ,6-diamidino-2-phenylindole; DMEM, Dulbecco's modified Eagle's medium; EGFP, enhanced green fluorescent protein; ER, endoplasmic reticulum; GST, glutathione transferase; IP, immunoprecipitation; NSF, N-ethylmaleimide-sensitive factor; pNPP, p-nitrophenylphosphate; SEAP, secreted alkaline phosphatase; SM, Sec1/Munc18; SNAP, soluble NSF-attachment protein; SNARE, soluble NSFattachment receptor; Stx, syntaxin; TMD, transmembrane domain; t-SNARE, target membrane-associated SNARE; VAMP, vesicle-associated membrane protein; v-SNARE, vesicle-associated SNARE; VSV-G, vesicular stomatitis virus G protein. 1 To whom correspondence should be addressed (email fussenegger@bsse.ethz.ch).
during exocytosis remains a major challenge and requires more insight into the various vesicle-trafficking routes in different organisms.
We have investigated the interaction of SM proteins with their cognate SNAREs and determined how these interactions are functionally coupled to assembly of SNARE complexes and subsequent exocytosis. Fusion of exocytic vesicles with the plasma membrane is catalysed by exocytic SNAREs, which include Stx3, SNAP-23 and VAMP2 or VAMP8, and three Munc18 proteins (a, b and c). Munc18a is essential for regulating exocytosis of neurotransmitters and hormones in neuronal and neuroendocrine cells. The finding that synaptic exocytosis was blocked completely in Munc18a-knockout mice [28] suggests that this SM protein stimulates secretory vesicle-membrane fusion [16] . Munc18c modulates secretion in a variety of nonneuronal cell types such as insulin-dependent trafficking of GLUT4 (glucose transporter 4)-containing vesicles in muscle and fat cells [13] . A recent study using cell-free systems has suggested that Munc18c impairs SNARE-mediated vesicle fusion [27] . Munc18b controls constitutive exocytosis by interacting with Stx3 [30] [31] [32] , but the molecular mechanism and the functional consequences of the Munc18b interaction with exocytic SNAREs have not yet been explored.
In the present study, we have shown that Munc18b interacts not only with Stx3, but also with non-Stxs such as VAMP8 and with the assembled exocytic core complex consisting of Stx3, SNAP-23 and VAMP8. Detailed functional and dynamic analyses of the Munc18b-Stx3 heterodimer revealed two Munc18b-binding sites on Stx3: the N-peptide and the closed-conformation C-terminus. This interaction, which neutralizes the exocytosis-inhibitory activity of Stx3, is responsible for the finding that ectopic expression of Munc18b increases the secretion of heterologous proteins in mammalian cells.
MATERIALS AND METHODS

Plasmid construction
The mammalian expression vector pRP25 (P hCMV -munc18b-pA SV40 ) was as described previously [33] . Polyhistidine (His n )-tagged Munc18b was expressed from pRP50 (His-Munc18b; P T7 -His 6 -munc18b-pA T7 ), constructed by inserting the PCR-amplified munc18b from pDNR-Dual-Munc18b (Open Biosystems) using ORP181 (5 -AGCCATATGGCTAGCGCGCCCTCGGGGCTG-AAG-3 ; NheI site underlined) and ORP182 (5 -CGCAAGCTT-GTCGACTCAGGGCAGGGCAATGTCCTCCAG-3 ; SalI site underlined), NheI/XhoI-ligated into pET28a (Novagen). pRP201 (Stx3-His; P T7 -stx3-His 10 -pA T7 ) was constructed by inserting stx3, PCR-amplified from pOTB7-Stx3 (Open Biosystems) using ORP142
(5 -CATGCCATGGACCGTCTGGAGCAGCTG-3 ; NcoI site underlined) and ORP143 (5 -CGCGGATCCTTAA-TGATGATGATGATGATGATGATGATGATGTTTCTTCCGG-GCCTGACTCTG-3 ; BamHI site underlined), NcoI/BamHIligated into pET19b (Novagen). Similarly, pRP202 (SNAP-23-His; P T7 -SNAP-23-His 10 -pA T7 ) was created by inserting fulllength snap-23, PCR-amplified from pGEX4T-1-SNAP-23 [13] using ORP140 (5 -CATGCCATGGATAATCTGTCCCCAGAG-3 ; NcoI site underlined) and ORP141 (5 -CGCGGATCCTTA-ATGATGATGATGATGATGATGATGATGATGACTATCA-ATGAGTTTCTTTGC-3 ; BamHI site underlined), NcoI/BamHIligated into pET19b. Constructs expressing His-VAMP2 (P T7 -His 6 -VAMP2 [7] ), His-VAMP8 (P T7 -His 6 -VAMP8 [7] ), GST (glutathione transferase)-tagged VAMP2 (GST-VAMP2 [20] ), GST-SNAP-23 (P tac -GST-SNAP-23 [13] ), GST-VAMP8 (P tac -GST-VAMP8 [34] ), GST-Stx3 (P tac -GST-Stx3 [35] ), GST-Stx4 (P tac -GST-Stx4 [36] ) and GST-Bet1 (P tac -GST-Bet1 [23] ) were as described previously. The truncated Stx3 variants, GST-Stx3-(1-27), GST-Stx3-(28-260) were expressed from pRP105 [P tac -GST-Stx3(1-27)], pRP64 [P tac -GST-Stx3(28-260)] and pRP84 [P tac -GST-Stx3(187-260)] respectively. pRP105 was generated by inserting ORP261 (5 -AATTCTAACTAGTGGCGGAGGTG-GGAAGGACCGACTGGAGCAGCTGAAGGCCAAGCAGCT-GACGCAGGATGATGACACGGACGAGGTTGAGATTGCT-ATTGATTAAG-3 ) and ORP262 (5 -TCGACTTAATCAATAGC-AATCTCAACCTCGTCCGTGTCATCATCCTGCGTCAGCT-GCTTGGCCTTCAGCTGCTCCAGTCGGTCCTTCCCACCT-CCGCCACTAGTTAG-3 ), EcoRI/SalI-ligated into pGEX-KG [37] . pRP64 and pRP84 were created by inserting the respective stx3 fragment, PCR-amplified from pGEX-Stx3 (P tac -GST-Stx3) using ORP193 (5 -CGCCCGAGCGGAATTC-TAAATACAGCGTTCATGGATGAG-3 ; EcoRI site underlined) and ORP194 (5 -CGCGGCAGCGTCGACTTAAGCCTGAC-CCTGATACTTCATGGC-3 ; SalI site underlined), ORP215 (5 -CGCCCGAGCGGAATTCTAGGTGGTGGTTCCAAGCAAG-CCCTCAGCGAG-3 ; EcoRI site underlined) and ORP194, EcoRI/SalI-ligated into pGEX-KG. The soluble Stx3-(1-260) mutant proteins, GST-Stx3(L8E) and GST-Stx3(L165A/ E166A), were expressed from pRP111 [P tac -GST-Stx3(L8E)] and pRP203 [P tac -GST-Stx3(L165A, E166A)], which were generated from pGEX-Stx3 (P tac -GST-Stx3) using ORP147 (5 -GACCGACTGGAGCAGGAAAAGGCCAAGCAGCTG-3 ) and ORP148 (5 -CAGCTGCTTGGCCTTTTCCTGCTCCAGTCGG-TC-3 ), ORP276 (5 -ACAACAGATGAGGAGGCCGCTGAAA-TGTTGGAGAG-3 ) and ORP 277 (5 -CTCTCCAACATTTC-AGCGGCCTCCTCATCTGTTGT-3 ) respectively, with nucleotides encoding the mutated residues underlined, and the QuikChange ® II site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. The mammalian expression vector pRP91 (P hCMV -Myc-Stx3-pA BGH ), expressing Myc-Stx3-(1-290), was constructed by inserting the full-length stx3, PCR-amplified from pOTB7-Stx3 using ORP228 (5 -CGC-GGCAGCGGATCCACCATGGAACAAAACTCATCTCAGA-AGAGGATCTGGGAGGAAAGGACCGTCTGGAGCAGCTG-3 ; BamHI site underlined) and ORP229 (5 -CCGCTCGAGTT-AATTCAGCCCAACGGAAAGTCC-3 ; XhoI site underlined), BamHI/XhoI-ligated into pcDNA3.1 (Invitrogen). The pcDNA4-derived mammalian vectors pcDNA4/TO/Stx3-Myc 2 -His (P hCMV -Stx3-Myc 2 -His 6 -pA BGH ), expressing Stx3-(1-290)-Myc 2 -His 6 and pcDNA4/TO/Stx3d27-Myc 2 -His 6 (P hCMV -Stx3d27-Myc 2 -His 6 -pA BGH ) expressing the N-peptide deletion mutant Stx3-(28-290)-Myc 2 -His 6 , were purchased from Addgene.
To express C-terminally GST-tagged proteins, we engineered the vector pRP117 by inserting GST, PCR-amplified from pGEX-KG by ORP281 (5 -CATGCCATGGGCGGAATTCTAGACG-GTCGACTCGAGCTCAAGCTTGGTGGTGGTTCCCCTATA-CTAGGTTATTGG-3 ; NcoI and EcoRI/XbaI sites underlined) and ORP282 (5 -CGCGGCAGCGGATCCTCACG-ATTTTGGAGGATGGTCGCCACC-3 ; BamHI site underlined), NcoI/BamHI-ligated into pET19b. The C-terminally GST-tagged Stx3 fragments were expressed from pRP118 [P T7 -Stx3(1-260)-GST-pA T7 ] and pRP119 [P T7 -Stx3(28-260)-GST-pA T7 ] respectively, which were created by inserting the Stx3 fragments, PCR-amplified from GST-Stx3 (above) by ORP283 (5 -CA-TGCCATGGGCAAGGACCGACTGGAGCAGCTG-3 ; NcoI site underlined) and ORP288 (5 -CGCGGCAGCCTCGAG-AGCCGACCCTGATACTTCATGGC-3 ; XhoI site underlined), ORP285 (5 -CATGCCATGGGCAATACAGCGTTCATGGATG-AG-3 ; NcoI site underlined) and ORP288, NcoI/XhoI-ligated into pRP117. pRP120 [P T7 -Stx3(1-27)-GST-pA T7 ] was constructed by directly inserting ORP289 (5 -CATGGTAAAGGACCGAC-TGGAGCAGCTGAAGGCCAAGCAGCTGACGCAGGATGA-TGACACGGACGAGGTTGAGATTGCTATTGATC-3 ) and ORP290 (5 -TCGAGATCAATAGCAATCTCAACCTCGTCCG-TGTCATCATCCTGCGTCAGCTGCTTGGCCTTCAGCTGC-TCCAGTCGGTCCTTTAC-3 ), NcoI/XhoI-ligated into pRP117.
Stx3(L165A/E166A)-GST was expressed from pRP121 [P T7 -Stx3(L165A, E166A)-GST-pA T7 ], which was mutated from pRP118 by using ORP276, ORP277 and the QuikChange ® II sitedirected mutagenesis kit. His 6 -tagged Munc18c was expressed from pRSETa-Munc18c (P T7 -His 6 -Munc18c) [13] .
Protein expression and purification
Expression and purification of GST-and His n -tagged proteins from Escherichia coli were performed as described before [23] . In brief, plasmids were transformed into an E. coli strain C41 which was grown at 37
• C to a D 600 of 1 and recombinant protein production was induced for 4 h at 37
• C with 1 mM IPTG (isopropyl β-D-thiogalactopyranoside). Cells from 1-litre cultures were collected by centrifugation at 6000 g for 10 min at 4
• C, resuspended in 10 ml of buffer A (25 mM Tris/HCl, pH 7.5, 400 mM KCl, 10 % glycerol, 2 % Triton X-100 and 5 mM 2-mercaptoethanol) and lysed by sonication (30 s on/off cycles, 5 min, output power of 300 W) using a Bioruptor UCD-200TM-EX (Diagenode). Lysates were clarified by centrifugation at 10 000 g for 10 min at 4
• C, incubated with 1 ml of 50 % glutathione-agarose (GE Healthcare) or Ni-NTA (Ni 2+ -nitrilotriacetate)-agarose slurry (Qiagen) for 60 min at 4
• C and loaded on to a minicolumn (Pierce). Affinity matrices containing bound protein were then washed with 50 ml of buffer B (25 mM Tris/HCl, pH 7.5, 500 mM KCl, 10 % glycerol, 1 % Triton X-100 and 2 mM 2-mercaptoethanol), and the bound proteins were subsequently eluted with buffer C (buffer B containing 150 mM KCl instead of 500 mM) containing either 10 mM reduced glutathione (for GST-tagged proteins) or 250 mM imidazole (for His n -tagged proteins).
In vitro GST pull-down assay
A 15 μl volume of 50 % glutathione-Sepharose slurry was mixed with oversaturating amounts (>30 μg) of GST-fusion proteins for 60 min at 4
• C to exploit the full binding capacity. The slurry was then washed three times with buffer F (50 mM Tris/HCl, pH 7.5, 150 mM KCl, 10 % glycerol, 0.5 % Triton X-100 and 2 mM 2-mercaptoethanol) before being mixed with purified HisMunc18b in a total volume of 100 μl of buffer F, incubated for 120 min at 4
• C on a rotation wheel (model Stuart SB2, Dunn Labortechnik) at 20 rev./min and washed four times with buffer F. Proteins bound to the glutathione-containing beads were resolved on SDS/PAGE (12 % gels) and visualized by staining with Coomassie Blue and Western blotting.
In vitro SNARE complex assembly
An equimolar amount of GST-fusion proteins, reconjugated on to 15 μl of glutathione-Sepharose beads, were incubated for 14 h (unless stated otherwise) with oversaturating amounts (15 μg of SNAP-23 and 10 μg of VAMP2 or VAMP8) of His n -tagged SNARE proteins in a total volume of 100 μl of buffer F at 4
• C on a rotation wheel at 20 rev./min. After washing four times with buffer F, the bound proteins were resolved by SDS/PAGE (15 % gels) and visualized by staining with Coomassie Blue.
For the experiment shown in Figure 5 (B), 10 μg of C-terminally GST-tagged Stx3 proteins were incubated with Munc18b for 14 h. The Munc18b-Stx3-GST subcomplexes recovered by glutathione-Sepharose beads (15 μl) were incubated further with SNAP-23-His (5 μg) and His-VAMP8 (5 μg) in the absence or presence of Stx3-(1-27)-GST (10 μg) in a total volume of 100 μl of buffer F. The reaction proceeded for 12 h at 4
• C and was analysed as above.
Mammalian cell culture, transfection and design of transgenic cell lines
Human cervical adenocarcinoma cells (HeLa; A.T.C.C. CCL-2) were cultivated in standard DMEM (Dulbecco's modified Eagle's medium) (Invitrogen) supplemented with 10 % FBS (fetal bovine serum) (PAN Biotech) and 1 % penicillin/streptomycin solution (Sigma Chemicals). Transient transfections were performed using a modified calcium phosphate-based protocol [38] . In brief, 10 5 cells/well were seeded in a 12-well plate and transfected 24 h later with a total of 2.2 μg of DNA, 5 μl of 2.5 M CaCl 2 , 50 μl of 2 × Bes-buffered saline (50 mM Bes, 280 mM NaCl and 1.5 mM sodium phosphate, pH 6.95) in a final volume of 100 μl. The culture medium was exchanged 6 h after transfection and the cells were incubated for another 48 h at 37
• C before further analysis. The transgenic Munc18b-and Stx3-(1-290)-expressing HeLa-derived cell lines, HeLa-Munc18b [33] and HeLa-Stx3, were constructed by transient transfection of pRP25 and pRP91 respectively, followed by selection and clonal expansion in standard medium supplemented with 800 μg/ml G418 (Calbiochem).
(Co-)immunoprecipitation and Western blot analysis
Next, 5 × 10 7 HeLa cells and its transgenic derivatives HeLaMunc18b and HeLa-Stx3 cells were lysed in 2.5 ml of lysis buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA and 1 % Triton X-100) for 30 min on ice. After centrifugation at 14 000 g for 10 min at 4
• C, the supernatant was incubated with 50 μl of Protein GSepharose slurry (GE Healthcare) for 30 min at 4
• C to remove unspecific binding components. The cleared lysates, obtained by centrifugation at 14 000 g for 10 min at 4
• C, were subjected to IP (immunoprecipitation) by mixing 2 mg of lysate protein with 15 μg of affinity-purified anti-Munc18b (Santa Cruz Biotechnology) or anti-Myc (Santa Cruz Biotechnology) antibodies coupled to Protein G-Sepharose and incubated at 4
• C overnight on a rotation wheel at 20 rev./min. The Protein GSepharose-containing slurry was washed four times with 500 μl of lysis buffer, and the bound proteins were separated by SDS/PAGE (15 % gels) and visualized by Western blot analysis using specific primary antibodies, horseradish-peroxidase-coupled secondary antibodies and ECL-Plus detection reagents according to the manufacturer's instructions (GE Healthcare). Other primary antibodies used in the present study included anti-Stx3 (Santa Cruz Biotechnology), anti-Stx4 (Synaptic Systems), anti-SNAP-23 (Synaptic Systems), anti-VAMP2 (Synaptic Systems), anti-VAMP8 (Synaptic Systems) and anti-Munc18c (Santa Cruz Biotechnology).
Quantification of Western blot results was carried out using a Gel-Pro Analyzer TM (Media Cybernetics). Typically, the signal density represented the average value of three independent experiments.
Quantification of protein production
The human placental SEAP (secreted alkaline phosphatase) was expressed from pSEAP2-Control (Clontech Laboratories; GenBank ® accession number U89938) and the SEAP production was quantified in the cell culture supernatant 48 h after transfection based on a pNPP (p-nitrophenylphosphate)-based light-absorbance time course [39] . One SEAP unit corresponds to the conversion of 1 μmol of pNPP per min. Production level results are expressed as means + − S.D. for at least three independent experiments.
Secretion kinetics and confocal fluorescence microscopy
The Munc18b-and Stx3-overexpressing HeLa derivatives HeLaMunc18b and HeLa-Stx3 were seeded on to poly-L-lysine-coated glass slides (10 4 cells/cm 2 ) and transiently transfected with pEGFPdKA206K-N1-VSVGtsO45 (P hCMV -EGFP-ts045-VSV-GpA SV40 ; provided by J. Lippincott-Schwartz) encoding a temperature-sensitive variant of the VSV-G (vesicular stomatitis virus G protein) (ts045-VSV-G) fused to EGFP (enhanced green fluorescent protein) which is folding-incompetent and remains stuck in the ER (endoplasmic reticulum) at 37
• C. EGFPts045-VSV-G will refold and be released from the ER at low temperatures and can then reach its terminal location (the plasma membrane) via the secretory pathway [40] . After transfection, the cells were incubated for 60 min at 37
• C and then for 16 h at 40 • C. After incubation for 30 min at 4
• C to assist the folding of EGFPts045-VSV-G, the culture medium was replaced by fresh DMEM pre-warmed to 32
• C. After the indicated chase periods, the cells were fixed with 4 % (w/v) paraformaldehyde in PBS (Invitrogen). Cell surface-localized EGFP-ts045-VSV-G was detected by a monoclonal antibody specific for VSV-G's luminal domain (provided by R. Pepperkok, EMBL, Heidelberg, Germany) and visualized using a Cy5 (indodicarbocyanine)-conjugated secondary antibody (Jackson ImmunoResearch Laboratories). Total cellular EGFP-ts045-VSV-G was visualized by EGFP fluorescence. The nucleus was stained with DAPI (4 ,6-diamidino-2-phenylindole) (Invitrogen). Microscopy and recoding of images were performed with a Leica TCS SP1 confocal microscope (a 63×, 1.4 numerical aperture lens) set-up with Leica confocal software installed.
RESULTS
Munc18b is a subunit of the exocytic fusion machinery interacting with Stx3, VAMP8 and assembled core SNARE complexes
In non-neuronal mammalian cells, fusion of constitutively exocytic vesicles with the plasma membrane is catalysed by Munc18b as well as exocytic SNAREs such as Stx3, SNAP-23, VAMP2 or VAMP8. We have successfully expressed all of these key fusion players as GST-and/or His n -tagged full-length (Munc18b and SNAP-23) or soluble (Stx3, VAMP2 or VAMP8) fusion proteins in E. coli and purified them by corresponding affinity chromatography ( Figure 1A) . In vitro GST pull-down assays consisting of mixing GST-SNAREs bound to glutathioneSepharose with Munc18b and follow-up analysis by Coommassie Blue-stained SDS/PAGE ( Figure 1B, upper panel) or Western blots ( Figure 1B, lower panel) confirmed the interaction of Munc18b with Stx3 [30] [31] [32] , but also revealed that this SM protein specifically binds to the non-Stx SNARE VAMP8 (Figures 1B  and 1C ). In contrast, Munc18c, which is the homologue of Munc18b and interacts with Stx4 and VAMP2 [13, 27] , did not cross-react with Stx3 or VAMP8 ( Figures 1B and 1C) , indicating the specificity of SM-SNARE interactions. This newly identified Munc18b-VAMP8 interaction suggests that, akin to Sly1 [26] , Vps45 [24] , Munc18a [16] and Munc18c [27] , Munc18b binds to non-Stx SNAREs of the respective fusion pathways. Since most SM proteins also interact with assembled core SNARE complexes, we have also determined whether Munc18b retains this property. Stx3 and SNAP-23 forms specific SNARE complexes with either VAMP2 or VAMP8, but not with Bet1, a SNARE involved in vesicular fusion with the Golgi (Figure 2A ). Munc18b was able to bind both core SNARE complexes, Stx3-SNAP-23-VAMP2 and Stx3-SNAP-23-VAMP8 in GST pull-down assays using either GST-Stx3 or GST-SNAP-23 ( Figures 2B and 2C) , clearly demonstrating that Munc18b interacts with the assembled SNARE complexes.
The in vivo interaction of Munc18b with the exocytic core SNARE complexes was explored further by co-IP experiments. HeLa lysates were subjected to immunoprecipitation by affinitypurified anti-Munc18b antibodies, and the co-precipitated proteins were analysed by Western blotting. As shown in Figure 2 (D), anti-Munc18b antibodies not only quantitatively precipitated Munc18b, but also fractions of Stx3, SNAP-23, VAMP2 and VAMP8. In contrast, Stx4, which forms complexes with SNAP-23 and VAMP2 and interacts directly with Munc18c ( Figure 1B) , was absent from precipitates produced by antiMunc18b antibodies ( Figure 2D) , thus confirming the specific interaction of Munc18b with the exocytic core SNARE complex in vivo.
The N-peptide of Stx3 interacts directly with Munc18b
Stx3 consists of a C-terminal TMD and an N-terminus which is exposed to cytoplasm. The extreme N-terminus contains a short peptide, known as N-peptide, which is followed by three α-helical bundles (Habc domains), an unfolded linker and another GST-Stx3 as well as GST alone and GST-Bet1 were mixed with equal amounts of His n -tagged SNAREs (SNAP-23 and VAMP2 or VAMP8) and incubated for 14 h at 4 • C. The complexes formed on glutathione-Sepharose beads were analysed by SDS/PAGE followed by staining with Coomassie Blue. (B) Munc18b bound to assembled exocytic core SNARE complexes consisting of Stx3, SNAP-23 and VAMP8. Pre-formed exocytic core SNARE complexes with GST-Stx3 were subjected to GST pull-down assays and the GST-tagged proteins were visualized by staining with Coomassie Blue (upper panel), while bound Munc18b was stained by immunoblotting (lower panel). (C) As (B), except that GST-SNAP-23 was used for SNARE complex assembly. (D) HeLa cell lysate (5 % of total), lysate co-immunoprecipitated using affinity-purified anti-Munc18b antibodies and supernatant (5 % of total) were analysed by immunoblotting using antibodies specific for Munc18b, Stx3, SNAP-23, VAMP8, VAMP2 and Stx4. Molecular masses are indicated in kDa.
α-helical bundle (H3 or SNARE motif), which pairs with the H3 of its partner SNAREs to form the conserved four α-helices assembly, the SNARE complex ( Figure 3A) . To dissect the bimolecular interaction of Munc18b with Stx3, we expressed various truncated soluble Stx3 versions (amino acids 1-27, 28-260 and 1-260) and assessed their interaction with Munc18b in GST pull-down assays. Stx3-(28-260), lacking the N-peptide (amino acids 1-27), and Stx3(L8E), harbouring a single amino acid substitution in the N-peptide, both interact with Munc18b ( Figure 1B and results not shown) . However, the N-peptide alone [GST-Stx3-(1-27)] was not sufficient to capture Munc18b in GST pull-down assays (results not shown), probably due to the interference of the N-terminal GST moiety [17, 41] . To test this possibility, we expressed the C-terminally GST-tagged Stx3 proteins and analysed their binding in the same way by pull-down assays. Under this condition, the N-peptide, Stx3-(1-27)-GST, could bind Munc18b efficiently, although the affinity was much weaker than the C-terminal Stx3-(28-260)-GST ( Figure 3B ), suggesting that both the Stx3 N-peptide and the C-terminus are involved in binding Munc18b ( Figures 1B, 3B and 3C) .
The (Figure 3C, lane 3) , indicating that the Stx3 Npeptide plays a critical role in the interaction with Munc18b. All these results establish that, as for other SM protein-Stx interactions (Sly1-Stx5 [12] , Vps45-Stx16 [11] , Munc18a-Stx1 [15] [16] [17] , Munc18c-Stx4 [13] ), the N-peptide is critical for the Munc18b-Stx3 interaction.
Munc18b binds to the closed-conformation C-terminus of Stx3
Munc18a binds with high affinity the closed-conformation Cterminus of Stx1, in which the Habc domain folds back and interacts intramolecularly with the H3 domain [18, 20] . This interaction involves extensive contacts between the inner surface of the arch-shaped Munc18a and most of the Stx1 protein, with the exception of the N-peptide, which inserts into the outer surface of the SM protein [10, 17, 19] .
To determine whether the C-terminus of Stx3 also adopts a closed conformation to interact with Munc18b, we introduced the LE mutation (L165A/E166A) into the Stx3 linker region, which keeps the C-terminus locked in an open conformation by preventing any interaction between the Habc and H3 domains [18] . Two soluble LE mutants, GST-Stx3- LE and Npeptide-deleted GST-Stx3-(28-260) LE , were created, and both were active in SNARE complex formation ( Figure 4A) . To probe the effect of conformational change on Stx3's binding with Munc18b, we used C-terminally GST-tagged Stx3 [Stx3-(1-260)-GST] and its LE mutant [GST-Stx3(L165A/E166A)], since the N-terminal GST moiety interferes with the binding of Stx3 Npeptide with Munc18b ( Figure 3 ). As shown in Figure 4(B),  Stx3-(1-260) LE -GST bound Munc18b, but the affinity was much reduced. These results suggest that the C-terminal domain of Stx3 adopts a closed conformation which is required for Munc18b binding.
Munc18b affects core SNARE complex assembly
To gain insights into the mechanistic impact of the Munc18b-Stx3 interaction on the assembly of the core SNARE complex, which represents a crucial step in fusion of secretory vesicles to the plasma membrane, we assessed the impact of Stx3 variants on core SNARE complex assembly in the presence or absence of Munc18b. In the absence of Munc18b, soluble Stx3-(28-260) assembled into core SNARE complexes with SNAP-23 and VAMP8 as efficiently as soluble wild-type Stx3-(1-260) ( Figure 5A ). However, in the presence of Munc18b, the preformed Munc18-Stx3-(28-260)-GST subcomplex assembled efficiently into SNARE complexes, whereas Munc18b-Stx3-(1-260)-GST was no longer able to interact with its partner SNAREs ( Figure 5B) . Moreover, addition of purified Stx3-(1-27)-GST did not prevent Munc18b-Stx3-(28-260)-GST subcomplex from complex formation with SNAP-23 and VAMP8. These findings suggest (i) that Munc18b interferes with Stx3 in assembling into core SNARE complexes, (ii) that this interference requires interaction with the N-peptide, and (iii) the interference requires the intact Stx3- . This is consistent with a previous study showing that Munc18a blocks Stx1 from assembling into a synaptic SNARE complex by a similar mechanism [17] . The positive role of Munc18b in constitutive exocytosis was confirmed by analysing the trafficking of EGFP-ts045-VSV-G, a transmembrane cargo molecule that traverses along the secretory pathway to reach the plasma membrane as its final destination. Therefore EGFP-ts045-VSV-G, which is retained in the ER at 40
• C due to misfolding and moves into the secretory pathway at 32
• C [40] , was expressed in HeLa cells also overexpressing either Munc18b or Stx3. The engineered cells were first kept at high temperature followed by a chase incubation period at 32
• C to elucidate the dynamics and capacity of the secretory machinery. As shown for HeLa-Munc18b, EGFP-ts045-VSV-G predominantly accumulated in widely dispersed ER membranes (green fluorescence) at 40
• C (t = 0), moved into the juxtanuclear Golgi complex within 30 min after shifting to 32
• C ( Figure 6B ) and, after 60 min, nearly all of the EGFP-ts045-VSV-G had reached the plasma membrane ( Figure 6B ). At similar overall EGFP-ts045-VSV-G expression levels, Munc18b-overexpressing cells ( Figure 6B ) always showed higher EGFP-ts045-VSV-G trafficking kinetics and had more EGFP-ts045-VSV-G at the cell surface compared with Stx3-overexpressing ones ( Figure 6C ), suggesting that Munc18b stimulates trafficking of EGFP-ts045-VSV-G from the ER via the Golgi to the plasma membrane, while Stx3 has the opposite effect.
DISCUSSION
We have used soluble exocytic SNAREs for assembly into specific core complexes to determine how the SM family proteins interact with their cognate SNAREs and whether these interactions have an effect on the assembly of the core SNARE complex and subsequent exocytosis. We found that, in addition to the previously identified binding partner Stx3, Munc18b also interacts directly with the non-Stx protein VAMP8 and the exocytic assembled core SNARE complex including Stx3, SNAP-23 and VAMP8. These newly identified interactions indicate that Munc18b belongs to the same category as the SM proteins Sly1, Vps45, Munc18a and Munc18c, all of which bind cognate non-Stx SNAREs [16, 24, 26, 27] and interact with the assembled core SNARE complexes of the respective fusion pathways [13, 16, [22] [23] [24] [25] .
We have shown that Stx3, like most Stxs (Stx1, Stx4, Stx5 and Stx16), contains a conserved short sequence at the extreme Nterminus of the protein, known as the N-peptide, which is essential for binding to cognate SM proteins (Munc18a, Munc18c, Sly1 and Vps45) such as Munc18b [11] [12] [13] [15] [16] [17] (Figure 3 ). This is consistent with structural and biochemical studies showing that the N-peptides of Stx1, Stx4 and Stx5 bind via a conserved residue with a hydrophobic pocket of Munc18a, Munc18c and Sly1 [10, 14, 17] , and that mutation of the conserved residue of the Npeptide and/or the hydrophobic pocket of the SM protein prevent for ectopic Munc18b and Stx3 expression respectively, were transfected with the EGFP-ts045-VSV-G-encoding plasmid. After incubation at 40 • C which left EGFP-ts045-VSV-G stuck in the ER, the trafficking of EGFP-ts045-VSV-G was induced and chased at 32 • C for 10, 30 and 60 min. The cells were fixed and the surface-exposed EGFP-ts045-VSV-G was visualized by immunofluorescence using an Cy5-conjugated antibody specific for the luminal domain of VSV-G variant (red; lower panels), whereas the total cellular EGFP-ts045-VSV-G was visualized by GFP (green fluorescent protein) fluorescence (green; upper panels). The nucleus was stained with DAPI (blue).
the SM protein-SNARE interaction [11] [12] [13] [15] [16] [17] 24, 26] . Thus the N-peptide which is conserved among presently known Stxs is also present in Stx3 and was found to be essential for its interaction with Munc18b.
Since Stx3 N-peptide deletion mutants still bind Munc18b, although with reduced affinity, the remaining C-terminus of Stx3 may contain an additional Munc18b-interaction motif (Figure 3) . Further analyses revealed that the structural integrity of the entire C-terminus of Stx3 is essential for binding to Munc18b, since deletion of Stx3's Habc domain abolished any interaction between the Stx3 C-terminus and Munc18b (results not shown). Likewise, engineering of a LE mutation into Stx3 significantly reduced the affinity with Munc18b ( Figure 4B ). It has been shown that the C-terminus of Stx1, Stx4 and Stx16 adopts a closed conformation when bound to Munc18a, Munc18c or Vps45 [17] [18] [19] [20] [21] 42] , and that the Stxs harbouring LE mutations, which destabilize the closed conformations, show reduced affinity between the Stx and SM proteins [17, 18] . All of these findings indicate that the Stx3 C-terminus is bound to Munc18b in a closed conformation which is structurally related to the closed conformations of Stx1, Stx4 and Stx16 [18, 21, 42] . Therefore Munc18b can be catalogued together with Munc18a, Munc18c and Vps45 as SM proteins which interact with the N-peptide as well as the closed C-terminus of their cognate Stxs.
Although the details of how SM proteins affect vesiclemembrane fusions remain largely elusive, working models suggest that SM proteins selectively affect (assist or prevent) the assembly of SNARE complexes by interacting with Stxs, non-Stx SNAREs or mature SNARE complexes [2, 8] . We have found that by interacting with the N-peptide of Stx3, Munc18b exerts a negative impact on SNARE complex formation ( Figure 5 ). Likewise, neuronal Munc18a was shown to jeopardize SNARE assembly by interacting with Stx1's N-peptide, and Sly1 was suggested to obstruct incorporation of non-Stx SNAREs Bet1 and Sft1 into SNARE complexes by titrating them away [26] . However, it may also be possible that, akin to Munc18a and Munc18b binding to the N-peptides of Stx1 [17] and Stx3 (the present study), Sly1 binds to Stx5's N-peptide and so prevents the insertion of this Stx into the core SNARE complex [17] .
The role of individual SM proteins during exocytosis remains elusive and therefore controversial. Since Munc18a prevents ternary core SNARE complex formation in vitro, it has been predicted to inhibit exocytosis [17, 20] . In contrast, exocytosis of calcium-dependent large dense-core vesicles was reduced 10-fold in Munc18a-deficient cells and could be increased by ectopic expression of Munc18a [43] . Likewise, the release of neurotransmitters was completely blocked in Munc18a-knockout mice [28] .
We have shown that ectopic expression of Munc18b enhances exocytosis of heterologous soluble cargo (SEAP [33] ) as well as the trafficking of a membrane protein (EGFP-ts045-VSV-G), suggesting that this SM protein assists in the assembly of cognate core SNARE complexes. In contrast, Stx3 was found to inhibit SEAP secretion and the trafficking of EGFP-ts045-VSV-G ( Figure 6 ). Although it cannot be excluded that ectopic Munc18b and Stx3 expression activate production of unrelated components affecting the secretory pathway, our results suggest that SM proteins are exocytosis-promoting factors [9, 33, 43, 44] . Consistent with our finding, Munc18b knockdown was recently shown to inhibit exocytic release (degranulation) in rat basophilic leukaemia cells (RBL-2H3) and human neutrophil granule exocytosis was blocked by Munc18b-specific antibodies [45, 46] .
Although intracellular protein trafficking is not yet fully understood, the overall picture of protein interactions and process dynamics is becoming increasingly complete so that bioengineers can now take over to design secretion-optimized production cell lines for biopharmaceutical manufacturing [33, 44, 47] , tissue engineering [48] or to devise therapeutic interventions for secretion-based diseases [49] .
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